How to buy ObsEva stock | $2.01

ObsEva SA is a biotechnology business based in the US. ObsEva shares (OBSV) are listed on the NASDAQ and all prices are listed in US Dollars. ObsEva employs 53 staff and has a trailing 12-month revenue of around USD$16,000.

How to buy shares in ObsEva

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for ObsEva. Find the stock by name or ticker symbol: OBSV. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until ObsEva reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$2.01, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of ObsEva, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of ObsEva. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

ObsEva share price

Use our graph to track the performance of OBSV stocks over time.

ObsEva shares at a glance

• Key figures

Information last updated 2021-01-11.

Latest market close	USD$2.01
52-week range	USD$1.63 - USD$6.3
50-day moving average	USD$2.1088
200-day moving average	USD$2.5901
Wall St. target price	USD$11.83
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-2.283

Buy ObsEva shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy ObsEva stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of ObsEva SA by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ObsEva price performance over time

Historical closes compared with the close of $2.01 from 2021-01-11

1 week (2021-01-07)	-3.37%
1 month (2020-12-16)	-8.22%
3 months (2020-10-16)	-18.29%
6 months (2020-07-16)	-31.63%

1 year (2020-01-16)	-50.98%
2 years (2019-01-16)	-85.17%
3 years (2018-01-16)	9.7
5 years (2016-01-13)	N/A

ObsEva financials

Revenue TTM	USD$16,000
Gross profit TTM	USD$16,000
Return on assets TTM	-48.56%
Return on equity TTM	-185.11%
Profit margin	0%
Book value	$0.403
Market capitalisation	USD$114.7 million

TTM: trailing 12 months

Shorting ObsEva shares

There are currently 1.0 million ObsEva shares held short by investors – that's known as ObsEva's "short interest". This figure is 2.3% down from 1.1 million last month.

There are a few different ways that this level of interest in shorting ObsEva shares can be evaluated.

ObsEva's "short interest ratio" (SIR)

ObsEva's "short interest ratio" (SIR) is the quantity of ObsEva shares currently shorted divided by the average quantity of ObsEva shares traded daily (recently around 1.3 million). ObsEva's SIR currently stands at 0.79. In other words for every 100,000 ObsEva shares traded daily on the market, roughly 790 shares are currently held short.

However ObsEva's short interest can also be evaluated against the total number of ObsEva shares, or, against the total number of tradable ObsEva shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ObsEva's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 ObsEva shares in existence, roughly 20 shares are currently held short) or 0.0248% of the tradable shares (for every 100,000 tradable ObsEva shares, roughly 25 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ObsEva.

Find out more about how you can short ObsEva stock.

ObsEva share dividends

We're not expecting ObsEva to pay a dividend over the next 12 months.

ObsEva share price volatility

Over the last 12 months, ObsEva's shares have ranged in value from as little as $1.63 up to $6.3. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ObsEva's is 0.9856. This would suggest that ObsEva's shares are less volatile than average (for this exchange).

ObsEva overview

ObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing OBE022, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

Frequently asked questions

• What percentage of ObsEva is owned by insiders or institutions?

  Currently 5.542% of ObsEva shares are held by insiders and 48.495% by institutions.

• How many people work for ObsEva?

  Latest data suggests 53 work at ObsEva.

• When does the fiscal year end for ObsEva?

  ObsEva's fiscal year ends in December.

• Where is ObsEva based?

  ObsEva's address is: Chemin des Aulx, 12, Geneva, Switzerland, 1228

• What is ObsEva's ISIN number?

  ObsEva's international securities identification number is: CH0346177709

• What is ObsEva's CUSIP number?

  ObsEva's Committee on Uniform Securities Identification Procedures number is: H5861P103